High-risk life insurance is aimed at individuals that insurers classify as having an elevated mortality risk. That assessment ...

For the first time ever, NTNU researchers have identified new characteristics of aggressive prostate cancer. The research lays a foundation for the possibility that aggressive prostate cancer can ...

In Ethiopia, people are currently suffering from a triad of disease burdens: infectious diseases, chronic non-communicable ...

The research lays a foundation for the possibility that aggressive prostate cancer can probably be detected through a few ...

Those who are fighting to stop patient access to mRNA technology are killing one of our best shots at a cure for cancer.

A single PSA test at midlife may identify men with a low risk of prostate cancer for up to 20 years, supporting longer screening intervals. Men with a low baseline PSA level at midlife have a low risk ...

As men get older, cancer rates increase throughout the body. We look for more options for treatment, in Prescription: Health.

According to the Centers for Disease Control and Prevention (CDC), the average life expectancy was 75.8 years for males, 81.1 years for females, and the average for both sexes is 78.4 years in 2023. 1 ...

Studies on whether pelvic lymph node dissection (PLND) provides a survival benefit in men with prostate cancer having surgery ...

Learn about prostate cancer, its diagnosis, treatment options, and the latest study findings. Understand which types need ...

New research links PSA and PSA density to long-term prostate cancer risk, supporting risk-adapted screening strategies. Learn more about the 20-year findings.

A genetic test developed by researchers at Broad Clinical Labs and the U.S. Department of Veterans Affairs (VA) is now enabling a large, nationwide clinical trial aimed at improving health care for ...